2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro*, J. Bohlius, David A. Cameron, Lissandra Dal Lago, J. Peter Donnelly, N. Kearney, G. H. Lyman, R. Pettengell, V. C. Tjan-Heijnen, J. Walewski, Damien C. Weber, C. Zielinski

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)8-32
JournalEuropean Journal of Cancer
Volume47
Issue number1
DOIs
Publication statusPublished - Jan 2011

Keywords

  • Antineoplastic agents
  • Filgrastim
  • Granulocyte colony-stimulating factor
  • Lenograstim
  • Neoplasms
  • Neutropenia
  • Pegfilgrastim
  • Guideline

Cite this